Reducing Burden in Care Partners of Community-Dwelling Persons with Dementia and Oropharyngeal Dysphagia

减轻社区居民痴呆症和口咽吞咽困难患者护理伙伴的负担

基本信息

项目摘要

We propose an NIH Stage I (R61) study to adapt, refine, and pilot test a Web-based Care Partner Tool for Feeding in Dysphagia (WeCareToFeedDysphagia), followed by an NIH Stage IV (R33) full-scale, 24-month, randomized controlled trial (RCT), to determine the efficacy of WeCareToFeedDysphagia for reducing burden in care partners of community-dwelling persons with Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD), diagnosed with oropharyngeal dysphagia (OD) during hospitalization. OD, a devastating syndrome that affects nearly 90% of hospitalized patients with AD/ADRD, is a significant predictor of care- partner burden, which, in turn, leads to poor care-partner and patient outcomes (e.g., quality of life, QoL). Our preliminary data indicate that, upon hospital discharge, care partners of patients with AD/ADRD face dramatic and persistent unmet OD-related caregiving needs: A. knowledge deficits; B. unrealistic management expectations; C. patient QoL considerations; D. inability to cope with patient’s frustration/refusal to eat dysphagia diets; and E. lack of competencies/skills. The overall goal of this proposal is to reduce burden in care partners of community-dwelling persons with AD/ADRD and OD using a single-component, easily administered, intervention that addresses unmet OD-related caregiving needs. Guided by a self-regulation theoretical framework, WeCareToFeedDysphagia will use written and video content, care-partner testimonials, frequently asked questions, and resource links, to: A. provide accurate information (e.g., dysphagia diets); B. set realistic expectations; C. identify/support feeding goals (QoL considerations); D. acknowledge/support care-partner feelings; and E. provide competencies/skills for OD management. The R61 phase will adapt, refine, and pilot test WeCareToFeedDysphagia to reduce care-partner burden by: adapting our existing web- based tool by incorporating stakeholder input (Aim 1), resulting in WeCareToFeedDysphagia; refining the tool through usability/acceptability testing (Aim 2); and conducting a pilot RCT (N=60) to determine the preliminary efficacy of WeCareToFeedDysphagia to reduce care-partner burden, as well as the feasibility of a subsequent full-scale RCT (Aim 3). We will assess care partner reported outcomes using technology (e.g., smartphones): 3-month post-hospital care-partner burden (primary outcome) and QoL (secondary outcome). The go/no-go criteria for the full-scale RCT is defined as: feasibility as ≥50% consented, ≤20% attrition at 3 months, and ≥80% tool engagement; and preliminary efficacy as effect size of ≥0.3 for reducing care-partner burden. The R33 phase will determine the efficacy of WeCareToFeedDysphagia to reduce care-partner burden by: conducting a 24-month, full-scale RCT (N=406) at 11 diverse Northwell Health hospitals (Aim 4) and conducting moderator and mediator analyses to examine the impact on intervention efficacy (Aim 5). The proposal directly responds to NIA’s strategic direction to develop effective interventions to reduce the burden of age-related diseases and improve QoL for persons with AD/ADRD and their care partners.
我们提出了一项NIH I阶段(R61)研究,以适应,完善和试点测试基于网络的护理伙伴工具 在吞咽困难(Wecaretofeeddysphagia)中进食,然后是NIH IV阶段(R33)全尺度,24个月, 随机对照试验(RCT),以确定Wecaretofeeddysphagia降低燃烧的效率 在患有阿尔茨海默氏病(AD)和广告相关痴呆症的社区居民的护理伙伴中 (AD/ADRD),在住院期间被诊断为口咽吞咽困难(OD)。 OD,毁灭性的 影响近90%的AD/ADRD患者的综合征是护理的重要预测指标 合作伙伴伯恩(Burnen)又导致护理人员和患者结果(例如,生活质量,QOL)。我们的 初步数据表明,住院后,是AD/ADRD患者的护理伙伴 和持续的未满足与OD相关的护理需求:A。知识定义; B.不切实际的管理 期望; C.患者QOL的注意事项; D.无法应付患者的挫败感/拒绝吃饭 吞咽困难饮食;和E.缺乏能力/技能。该提议的总体目标是减少伯恩的 使用单一组件的关怀社区居民的广告/ADRD和OD的伙伴很容易 管理的干预措施满足了未满足与OD相关的护理需求。在自我调节的指导下 理论框架,WecaretofeedDysphagia将使用书面和视频内容,Care-Partner证明, 常见问题和资源链接,至:A。提供准确的信息(例如吞咽困难饮食); B 设定现实期望; C.确定/支持喂养目标(QOL考虑因素); D.认可/支持 照顾好的感觉;和E.为OD管理提供能力/技能。 R61阶段将适应, 精炼和试点测试Wecaretofeeddysphagia减少护理伴侣Burnen:适应我们现有的网络 通过编码利益相关者输入(AIM 1)来基于工具,导致WecaretofeedDysphagia;完善工具 通过可用性/可接受性测试(AIM 2);并进行试点RCT(n = 60)以确定初步 Wecaretofeeddysphagia的功效减少了Care-Partner Burnen,以及随后的可行性 全尺度RCT(AIM 3)。我们将使用技术(例如智能手机)评估护理伙伴报告的结果: 3个月的院后护理伴侣伯恩(主要结果)和QOL(次要结果)。 GO/No-Go 全尺度RCT的标准定义为:可行性为≥50%的同意,≤20%的损耗在3个月,并且 ≥80%的工具参与;和初步有效性,效果大小≥0.3,减少了护理伴侣。这 R33阶段将确定Wecaretofeeddysphagia降低护理伴侣的效率: 在11个Divers Northwell Health Hospitals(AIM 4)和 进行主持人和调解人分析以检查对干预效率的影响(AIM 5)。这 提案直接回应了NIA的战略方向,以制定有效的干预措施,以减少燃烧 与年龄相关的疾病并改善了AD/ADRD及其护理伙伴的QOL。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael A Diefenbach其他文献

USING GROWTH CURVE MODELING TO EXAMINE QUALITY OF LIFE AMONG PROSTATE CANCER SURVIVORS: RESULTS FROM A 36 MONTHS LONGITUDINAL STUDY
  • DOI:
    10.1016/s0022-5347(08)61156-8
  • 发表时间:
    2008-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michael A Diefenbach;William Dudley
  • 通讯作者:
    William Dudley

Michael A Diefenbach的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael A Diefenbach', 18)}}的其他基金

Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
膀胱 CA 患者和护理人员的康复支持:多模式方法
  • 批准号:
    10216197
  • 财政年份:
    2018
  • 资助金额:
    $ 41.09万
  • 项目类别:
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
膀胱 CA 患者和护理人员的康复支持:多模式方法
  • 批准号:
    10436957
  • 财政年份:
    2018
  • 资助金额:
    $ 41.09万
  • 项目类别:
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
膀胱 CA 患者和护理人员的康复支持:多模式方法
  • 批准号:
    10672260
  • 财政年份:
    2018
  • 资助金额:
    $ 41.09万
  • 项目类别:
Novel Approach to Facilitate Decisions in Patients w/ Muscle Invasive Bladder CA
促进肌肉侵袭性膀胱 CA 患者决策的新方法
  • 批准号:
    8876159
  • 财政年份:
    2015
  • 资助金额:
    $ 41.09万
  • 项目类别:
Novel Approach to Facilitate Decisions in Patients w/ Muscle Invasive Bladder CA
促进肌肉侵袭性膀胱 CA 患者决策的新方法
  • 批准号:
    9057990
  • 财政年份:
    2015
  • 资助金额:
    $ 41.09万
  • 项目类别:
Decision Making For Active Surveillance in Prostate Cancer Patients and Spouses
前列腺癌患者和配偶主动监测的决策
  • 批准号:
    8534064
  • 财政年份:
    2012
  • 资助金额:
    $ 41.09万
  • 项目类别:
Decision Making For Active Surveillance in Prostate Cancer Patients and Spouses
前列腺癌患者和配偶主动监测的决策
  • 批准号:
    8386407
  • 财政年份:
    2012
  • 资助金额:
    $ 41.09万
  • 项目类别:
Brief Intervention to Improve QOL & Couple Functioning after Prostate Surgery
改善生活质量的简短干预
  • 批准号:
    8301574
  • 财政年份:
    2011
  • 资助金额:
    $ 41.09万
  • 项目类别:
Brief Intervention to Improve QOL & Couple Functioning after Prostate Surgery
改善生活质量的简短干预
  • 批准号:
    8190005
  • 财政年份:
    2011
  • 资助金额:
    $ 41.09万
  • 项目类别:
Trajectories of QOL in Prostate Cancer Survivors using Growth Curve Modeling
使用生长曲线模型研究前列腺癌幸存者的生活质量轨迹
  • 批准号:
    7476125
  • 财政年份:
    2008
  • 资助金额:
    $ 41.09万
  • 项目类别:

相似国自然基金

海洋缺氧对持久性有机污染物入海后降解行为的影响
  • 批准号:
    42377396
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
  • 批准号:
    32371616
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
  • 批准号:
    22379027
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
  • 批准号:
    32300624
  • 批准年份:
    2023
  • 资助金额:
    10 万元
  • 项目类别:
    青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
  • 批准号:
    52377215
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    $ 41.09万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 41.09万
  • 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
  • 批准号:
    10462257
  • 财政年份:
    2023
  • 资助金额:
    $ 41.09万
  • 项目类别:
Focused ultrasound for memory disorders
聚焦超声治疗记忆障碍
  • 批准号:
    10638189
  • 财政年份:
    2023
  • 资助金额:
    $ 41.09万
  • 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
  • 批准号:
    10678341
  • 财政年份:
    2023
  • 资助金额:
    $ 41.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了